In this first episode with our new host, SLAS Scientific Manager, Hannah Rosen, we talk to Steven Graves, CEO and Founder at BennuBio, Inc about their new, high-throughput, multiple parallel stream system for flow cytometry. Steve shares their biggest challenges in developing this technology and their goal in getting it out into commercial world where it can do the most good. Listen in to find out how their new system, the Velocyt®, can change research in flow cytometry and what makes it a game changer.
BennuBio was awarded the Ignite Award at the SLAS2022 International Conference and Exhibition for the best start up company
Upcoming SLAS Events: